| Theme | Life Style and Digestive Diseases | |
|---|---|---|
| Title | Microflora Targeted Therapies for Inflammatory Bowel Disease: Pro- and Prebiotics | |
| Publish Date | 2003/01 | |
| Author | Keiichi Mitsuyama | Second Department of Medicine, Kurume University School of Medicine |
| Author | Satoshi Matsumoto | Yakult Central Institute for Microbiological Research |
| [ Summary ] | Although the causes of the inflammatory bowel disease remain incompletely understood, increasing evidence implicates intestinal microflora in the pathogenesis of these disorders. Modulation of the intestinal flora therefore may offer a plausible therapeutic approach. While recent data support a potential therapeutic role for probiotics, prebiotics and synbiotics, such treatments need to be further assessed by large scale studies. A better understanding of the intestinal microflora and the mechanisms of their action may help us to develop more effective treatments for inflammatory bowel disease. | |